Qi Ning (琪宁)琪宁
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 浙江爱生药业有限公司(中国/浙江)Chinese legal name: 浙江爱生药业有限公司(中国/浙江)
主要成分Active Ingredients
- 黄体酮Huangti Tong
药物知识说明
黄体酮是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：黄体酮Huangti Tong。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：黄体酮-78714cbe成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 琪宁) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 黄体酮Huangti Tong.
Explore other medicines containing the same ingredient: 黄体酮 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 琪宁Recorded Chinese name: 琪宁
- 剂型Dosage form: 丸剂Pills
- 规格Specification: 0.1g*6粒0.1 g × 6 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 浙江爱生药业有限公司(中国/浙江)Chinese legal name: 浙江爱生药业有限公司(中国/浙江)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20031099
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20031099
Manufacturer
Chinese legal name: 浙江爱生药业有限公司(中国/浙江)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.1 g × 6 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20031099
生产企业
浙江爱生药业有限公司(中国/浙江)
适应症
1.用于预防未切除子宫且正在服用结合雌激素的绝经期妇女的子宫内膜增生。 2.继发性闭经。
用法用量
与雌激素（如结合雌激素、倍美力）联合使用：倍美力片：口服，1.25mg，每日一次，共22天；服用倍美力片第13天起服用本品，口服，200mg（2粒），每日2次，共10天。用于先兆流产和习惯性流产、经前期紧张综合症、无排卵型功血和无排卵型闭经，常规剂量为每日200mg-300mg（2粒-3粒），1次或2次服用。每次剂量不得超过200mg（2粒），服药时间最好远隔进餐时间。
不良反应
突破性出血、阴道点状出血、经量改变、闭经、体重增加或减少、宫颈鳞柱交界改变、宫颈分泌物性状改变、阻塞性黄疸、过敏伴或不伴瘙痒的皮疹、黑斑病、黄褐斑、发热、失眠。
禁忌
以下患者禁用：
1.对黄体酮或本品中其他成分过敏者；
2.阴道不明原因出血；
3.血栓性静脉炎、血管栓塞、脑中风或有既往病史者；
4.乳腺肿瘤或生殖器肿瘤。
注意事项
1.一旦出现血栓性疾病（如血栓性静脉炎、脑血管病、肺栓塞和视网膜血栓形成的临床表现）应立即停止用药。
2.出现突发性部分视力丧失或突发性失明、复视或偏头痛、应停止用药，进行检查。
贮藏
密封，置干燥处保存。
规格
0.1g*6粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.